Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G J Ossenkoppele

Showing results (111-120 of 152) with videos related to

Pageof 16
Sort By:
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 1998
Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?A A Brink, J J Oudejans, A J van den Brule, et al.
Leukemia|December 14, 2011
Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinibJ J W M Janssen, W Deenik, K G M Smolders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemiaG J Schuurhuis, H J Broxterman, G J Ossenkoppele, et al.
Histopathology|August 1, 1995
Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 casesJ Van Gorp, P C De Bruin, D M Sie-Go, et al.
Bone Marrow Transplantation|August 18, 2001
Storage of unprocessed G-CSF-mobilized whole blood in a modified Leibovitz's L15 medium preserves clonogenic capacity for at least 7 daysA M de Kreuk, A R Jonkhoff, A Zevenbergen, et al.
Blood|June 1, 1996
Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activityH J Broxterman, P Sonneveld, N Feller, et al.
Blood|September 1, 1995
BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytesJ J Oudejans, A J van den Brule, N M Jiwa, et al.
Journal of Clinical Pathology|July 9, 1999
A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomasD F Dukers, R L ten Berge, J J Oudejans, et al.
Leukemia|February 20, 1999
Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?H J Broxterman, P Sonneveld, R Pieters, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1996
High-dose melphalan with re-infusion of unprocessed, G-CSF-primed whole blood is effective and non-toxic therapy in multiple myelomaG J Ossenkoppele, G J Schuurhuis, A R Jonkhoff, et al.
Pageof 16

Showing results (111-120 of 152) with videos related to

Sort By:
Pageof 16
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 13, 1998
Low p53 and high bcl-2 expression in Reed-Sternberg cells predicts poor clinical outcome for Hodgkin's disease: involvement of apoptosis resistance?A A Brink, J J Oudejans, A J van den Brule, et al.
Leukemia|December 14, 2011
Residual normal stem cells can be detected in newly diagnosed chronic myeloid leukemia patients by a new flow cytometric approach and predict for optimal response to imatinibJ J W M Janssen, W Deenik, K G M Smolders, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|January 1, 1995
Functional multidrug resistance phenotype associated with combined overexpression of Pgp/MDR1 and MRP together with 1-beta-D-arabinofuranosylcytosine sensitivity may predict clinical response in acute myeloid leukemiaG J Schuurhuis, H J Broxterman, G J Ossenkoppele, et al.
Histopathology|August 1, 1995
Nasal T-cell lymphoma: a clinicopathological and immunophenotypic analysis of 13 casesJ Van Gorp, P C De Bruin, D M Sie-Go, et al.
Bone Marrow Transplantation|August 18, 2001
Storage of unprocessed G-CSF-mobilized whole blood in a modified Leibovitz's L15 medium preserves clonogenic capacity for at least 7 daysA M de Kreuk, A R Jonkhoff, A Zevenbergen, et al.
Blood|June 1, 1996
Quality control of multidrug resistance assays in adult acute leukemia: correlation between assays for P-glycoprotein expression and activityH J Broxterman, P Sonneveld, N Feller, et al.
Blood|September 1, 1995
BHRF1, the Epstein-Barr virus (EBV) homologue of the BCL-2 protooncogene, is transcribed in EBV-associated B-cell lymphomas and in reactive lymphocytesJ J Oudejans, A J van den Brule, N M Jiwa, et al.
Journal of Clinical Pathology|July 9, 1999
A cytotoxic phenotype does not predict clinical outcome in anaplastic large cell lymphomasD F Dukers, R L ten Berge, J J Oudejans, et al.
Leukemia|February 20, 1999
Do P-glycoprotein and major vault protein (MVP/LRP) expression correlate with in vitro daunorubicin resistance in acute myeloid leukemia?H J Broxterman, P Sonneveld, R Pieters, et al.
European Journal of Cancer (Oxford, England : 1990)|November 1, 1996
High-dose melphalan with re-infusion of unprocessed, G-CSF-primed whole blood is effective and non-toxic therapy in multiple myelomaG J Ossenkoppele, G J Schuurhuis, A R Jonkhoff, et al.
Pageof 16